IC-OS International Cardio-Oncology Society
251 videos | 826 followers
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimizing the cardiac status of patients with cancer before, during and after their treatment, we are collectively improving the overall outcomes including survival and quality of life. We aim to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.
Global Cardio-Oncology Summit 2021
Session 3 - Year in Review: Key Developments in Cardio-Oncology
IC-OS International Cardio-Oncology Society
Session 4 - How to Talk About Your Work in a Way That Maximizes Audience Engagement.
IC-OS International Cardio-Oncology Society
Session 5 - Keynote Debate: Imaging Guided Cardioprotective Strategies – Ready for Prime Time?
IC-OS International Cardio-Oncology Society
Prostate Cancer Course - Available for free CME credit
Miscellaneous Topics in Cardio-oncology
Cardiovascular Considerations for Patients Undergoing Stem Cell Transplantation
IC-OS International Cardio-Oncology Society
The Dynamics of Cardio-Vascular Risk Stratification in Patients with Cancer
IC-OS International Cardio-Oncology Society
Statins to Prevent the Cardiotoxicity from Anthracyclines: The STOP-CA Trial
IC-OS International Cardio-Oncology Society
Carcinoid heart disease - Looking beyond the right side
IC-OS International Cardio-Oncology Society
Renal Cell Carcinoma and VEGF TKI Cardiovascular Toxicity
IC-OS International Cardio-Oncology Society
Novel insights into the mechanisms of ICI-related cardiotoxicity
IC-OS International Cardio-Oncology Society
Chemo-induced Cardiomyopathy - Beyond Left Ventricular Systolic Dysfunction
IC-OS International Cardio-Oncology Society
Innovative Approaches to Addressing Exercise Intolerance Among Cancer Survivors
IC-OS International Cardio-Oncology Society
Treating and Assessing Treatment Response: AL Amyloidosis
IC-OS International Cardio-Oncology Society
The challenge of managing pulmonary hypertension in cancer patients
IC-OS International Cardio-Oncology Society
How to use cardiac and oncologic markers during prostate cancer therapy
IC-OS International Cardio-Oncology Society
Managing Amyloidosis: What You Need to Know Now and For the Future
IC-OS International Cardio-Oncology Society
How to use cardiac and endocrine biomarkers during immune checkpoint inhibitor therapy
IC-OS International Cardio-Oncology Society
IC-OS Weekly Webinar - Board Exam Review Session
IC-OS International Cardio-Oncology Society
IC-OS Weekly Webinar - ICI Myocarditis: A Pharmacy Perspective
IC-OS International Cardio-Oncology Society
IC-OS Weekly Webinar - How to use cardiac and hematologic biomarkers during the treatment of multiple myeloma and amyloidosis
IC-OS International Cardio-Oncology Society
IC-OS Weekly Webinar - Managing Hypertension During TKI Therapy Part II
IC-OS International Cardio-Oncology Society
How to use cardiac hematolologic biomarkers during the treatment of lymphoma and leukemia
IC-OS International Cardio-Oncology Society
IC-OS Weekly Webinar - Managing hypertension during TKI therapy
IC-OS International Cardio-Oncology Society
How to use cardiac and oncology biomarkers during breast cancer therapy to assess risk and monitor treatment progress
IC-OS International Cardio-Oncology Society
Cases in Cardio-Oncology: Utility of Cardiac MRI in Patient Care Decisions
IC-OS International Cardio-Oncology Society
Risk of Cardiovascular Disease in Women Breast Cancer: The Pathways Heart Study
IC-OS International Cardio-Oncology Society
IC-OS Weekly Webinar - Tough Clinical Cases in Cardio-Oncology
IC-OS International Cardio-Oncology Society
IC-OS Weekly Webinar - Between a Rock and a Heart Place: Arrhythmias in Targeted Therapies
IC-OS International Cardio-Oncology Society
IC-OS Weekly Webinar - Immune Checkpoint Inhibitor Myocarditis
IC-OS International Cardio-Oncology Society
Update on Newer Therapy for AL Amyloidosis, A True Cardiac Diagnostic Emergency
IC-OS International Cardio-Oncology Society
Definitions of Cardiovascular Toxicities: A Recent IC-OS Statement
IC-OS International Cardio-Oncology Society
Ethical Considerations in Nutrition: Are We What We Eat?
IC-OS International Cardio-Oncology Society
The Role of Bruton Tyrosine Kinase Inhibitors (BTKi) in Chronic Lymphocytic Leukemia Treatment and Cardiotoxicity Management
IC-OS International Cardio-Oncology Society
Topics in Cardio-Oncology: Board Exam Review Course - October 2021
IC-OS International Cardio-Oncology Society
PRONOUNCE TRIAL : Behind the scenes, overview, discussion, and lessons learned.
IC-OS International Cardio-Oncology Society
Cardiovascular Effects of Therapeutic Radiation: 2021 ICOS Recommendations
IC-OS International Cardio-Oncology Society
The surgical management of coronary artery disease and valve disease in the oncology patient
IC-OS International Cardio-Oncology Society
Vascular Complications in the Oncology Patient: A focus on venous thromboembolism
IC-OS International Cardio-Oncology Society
IC-OS Monthly Case Review Webinars
Optimal Timing of a Physical Exercise Intervention to Improve Cardiorespiratory Fitness
IC-OS International Cardio-Oncology Society
Practical Considerations in Cardio-Oncology Drug Interactions: A Case-Based Series
IC-OS International Cardio-Oncology Society
Advanced heart failure therapies in cardio-oncology
IC-OS International Cardio-Oncology Society
The forgotten side of Cardio-oncology: unusual case of cardiac tamponade
IC-OS International Cardio-Oncology Society
Women With History of Hodgkin’s Lymphoma & Peripartum Cardiomyopathy
IC-OS International Cardio-Oncology Society
TKI associated Cardiotoxicity in hematologic malignancy patients: impacts of FLT3 inhibitors
IC-OS International Cardio-Oncology Society
Pericardial effusion in a stage IV lung cancer patient
IC-OS International Cardio-Oncology Society
IC-OS Monthly Journal Club Webinar
Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines
IC-OS International Cardio-Oncology Society
Clinical, Echocardiographic, and Biomarker Associations With Impaired Cardiorespiratory Fitness Early After HER2-Targeted Breast Cancer Therapy
IC-OS International Cardio-Oncology Society
Extreme Cardio-Oncology Cases: Challenges for the Practitioner
IC-OS International Cardio-Oncology Society
Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients with Immune Checkpoint Inhibitor-Associated Myocarditis
IC-OS International Cardio-Oncology Society
Contribution of Polygenic Risk to Hypertension Among Long-Term Survivors of Childhood Cancer
IC-OS International Cardio-Oncology Society
Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis
IC-OS International Cardio-Oncology Society
Heart Transplantation in Adriamycin-Associated Cardiomyopathy in the Contemporary Era of Advanced Heart Failure Therapies
IC-OS International Cardio-Oncology Society
Journal Club discussion of “Angiotensin system inhibitors may improve outcomes of patients with castration-resistant prostate cancer during abiraterone acetate treatment” – Front Oncol 2021
IC-OS International Cardio-Oncology Society
IC-OS Journal Club Webinar: Global longitudal strain and cardiac events in patients with immuno checkpoint inhibitor-related myocarditis
IC-OS International Cardio-Oncology Society
IC-OS - Cardiac Biomarkers During Cancer Therapy: Practical Applications for Cardio-Oncology
IC-OS International Cardio-Oncology Society
Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy
IC-OS International Cardio-Oncology Society
Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis
IC-OS International Cardio-Oncology Society
Introductory Issues in Cardio-Oncology
Inhibitors of the Vascular Endothelial Growth Factor Signaling Pathway (VSP)
IC-OS International Cardio-Oncology Society
IC-OS Topics in Cardio-Oncology - Exercise and Cancer Therapy
IC-OS International Cardio-Oncology Society
Immune check point inhibitors: Cardiovascular effect
IC-OS International Cardio-Oncology Society
Venous and Arterial Thromboembolism in Cancer Patients
IC-OS International Cardio-Oncology Society
Pediatric Cardio-Oncology
Course: Cardiac Amyloidosis: A Zebra or a Horse
Cardiac Amyloidosis: A Zebra or a Horse? Treatment of Cardiac Amyloidosis - November 2021
IC-OS International Cardio-Oncology Society
Covid-19 and Cardio-Oncology Webinars 2020
An unusual case of TKI-related cardiotoxicity: Cardio-Oncology in the COVID19 era
IC-OS International Cardio-Oncology Society
Cardio-Oncology In the Era of COVID-19: a Trans-Continental Perspective
IC-OS International Cardio-Oncology Society
IC-OS Imaging Working Group Webinars
IC-OS Weekly Webinar - Cardiac Computed Tomographic Imaging in Cardio-Oncology: An Expert Consensus Statement from the Society of Cardiovascular Computed Tomography
IC-OS International Cardio-Oncology Society
IC-OS Weekly Webinar - Heart Failure with Preserved Ejection Fraction in Cardio-Oncology: Is There a One Stop Best Imaging Test?
IC-OS International Cardio-Oncology Society
IC-OS Weekly Webinar - Multimodality Imaging Approach for Diagnosing Cardiac Amyloidosis
IC-OS International Cardio-Oncology Society
Cardiac toxicity of Anthracyclines in older adults with lymphoma: Predictive factors and monitoring recommendations
IC-OS International Cardio-Oncology Society
Immune Checkpoint Inhibitor Associated Myocarditis: Practical Evaluations
IC-OS International Cardio-Oncology Society
Nurses Working Group
Atherosclerosis with Immune Checkpoint Inhibitor Theraphy
IC-OS International Cardio-Oncology Society
Cardiovascular Follow up After Cardiotoxic Breast Cancer Therapies
IC-OS International Cardio-Oncology Society
The role of a specialist nurse in Cardio-Oncology
